发明名称 COMPUESTOS DERIVADOS DE 2,3-DIHIDROIMIDAZOL[1,2-C]QUINAZOLINA; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHOS COMPUESTOS; Y SU USO PARA TRATAR ENFERMEDADES Y TRASTORNOS HIPERPROLIFERATIVOS ASOCIADOS A LA ANGIOGENESIS, TALES COMO INFLAMACION, ENFERME
摘要 This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.
申请公布号 CL2007003508(A1) 申请公布日期 2008.07.04
申请号 CL20070003508 申请日期 2007.12.05
申请人 BAYER PHARMACEUTICALS CORPORATION, SOCIEDAD ANONIMA ORGANIZADA BAJO LAS LEYES DEL ESTADO DE DELAWARE 发明人 MARTIN HENTEMANN, JILL WOOD, WILLIAM SCOTT, ANN-MARIE CAMPBELL, ANN-MARIE BULLION, R. BRUCE ROWLEY,ANIKO REDMAN, MARTIN
分类号 A61K31/4745;A61P25/00;A61P35/00;C07D487/04 主分类号 A61K31/4745
代理机构 代理人
主权项
地址